(Press-News.org) Immunotherapy pioneer Dr. Antoni Ribas, professor of medicine at the David Geffen School of Medicine at UCLA and director of the tumor immunology program at the UCLA Health Jonsson Comprehensive Cancer Center, has been inducted into the 2024 Class of Fellows of the Academy of Immuno-Oncology by the Society for Immunotherapy of Cancer.
The recognition is one of the highest honors bestowed by the society and is given to scientists who have made seminal contributions in the field of cancer immunotherapy.
Ribas, an internationally renowned physician-scientist, has dedicated his career to improving the lives of people with cancer worldwide. His discoveries have led to the development of the immunotherapy drug pembrolizumab, marketed under the brand name Keytruda, to treat advanced melanoma. Pembrolizumab was the first of the class of PD-1–blocking antibodies to be approved by the U.S. Food and Drug Administration (FDA), transforming a once fatal disease to one that is often cured. Pembrolizumab has since gained approval for over 25 cancer indications, marking a significant advancement in cancer treatment.
Ribas also played a pivotal role in the FDA approval of several other cancer therapies, including the anti-CTLA-4 tremelimumab, and two combinations of BRAF and MEK inhibitors: vemurafenib and cobimetinib, as well as dabrafenib and trametinib. His ongoing research focuses on identifying novel mechanisms of resistance to immunotherapies and understanding how to identify patients who will and will not respond to them, with the goal of expanding the benefits of treatment to more individuals.
“It is an incredible honor to be recognized by the Society for Immunotherapy of Cancer and a privilege to join such esteemed colleagues, all of whom are dedicated to advancing impactful immunotherapy research and improving treatments for those facing the most challenging health conditions,” said Ribas.
Ribas, whose contributions to cancer research have earned him numerous national and international awards and grants, is a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and director of the Parker Institute for Cancer Immunotherapy Center at UCLA. Additionally, he is a former president of the American Association for Cancer Research (AACR), an elected Fellow of the AACR Academy, the American Society for Clinical Investigation, the Association of American Physicians and the National Academy of Medicine.
Ribas, one of six fellows, will be inducted during the society’s 39th Annual Meeting, taking place November 6-10 in Houston.
END
Physician-scientist named Academy of Immuno-Oncology fellow
2024-08-07
ELSE PRESS RELEASES FROM THIS DATE:
How media impacts digital technology adoption in U.S. and Brazilian agriculture
2024-08-07
URBANA, Ill. -- Digital technologies on the farm improve efficiency, productivity, and profits, but few farmers are taking full advantage of available tools. According to University of Illinois Urbana-Champaign researchers, communication channels play an important role in farmers’ decision-making process around technology adoption. A new study in the journal Agriculture looks at how traditional media, social media, and interpersonal meetings influence soybean farmers in the U.S. and Brazil, both world leaders in soybean production.
“Like everyone ...
New Center of Excellence at Chapman University will study quantum theory and the nature of reality
2024-08-07
An interdisciplinary team of scholars have received a $2.43 million dollar grant from the John Templeton Foundation to create a “Southern California Quantum Foundations Hub” at Chapman University. This unique collaboration includes theoretical physicists, experimental physicists and philosophers, who will apply the methods of their respective disciplines to provide deeper insights into the nature of reality that quantum theory is silent about. The Templeton Foundation has identified the area of quantum foundations ...
Breakthrough study reveals molecular subtypes of Down syndrome, offering insights for personalized medicine approaches
2024-08-07
A new study published in Nature Communications by researchers from the Linda Crnic Institute for Down Syndrome (Crnic Institute) at the University of Colorado Anschutz Medical Campus reports a significant breakthrough. The research, part of the ongoing Crnic Institute Human Trisome Project, identifies distinct molecular and immune subtypes across individuals with Down syndrome, offering new insights that could lead to personalized medicine approaches for the clinical management of this condition.
The Crnic Institute team analyzed the expression of genes encoded on chromosome 21, which is triplicated in those ...
Biophysical Society announces the results of its 2024 Elections
2024-08-07
ROCKVILLE, MD – Karen Fleming has been elected President-elect of the Biophysical Society (BPS). She will assume the office of President-elect at the 2025 Annual Meeting in Los Angeles, California and begin her term as President during the 2026 Annual Meeting in San Francisco, California.
Fleming is a Professor of Biophysics at Johns Hopkins University. She earned a Bachelor of Arts from the University of Notre Dame before going on to achieve a PhD in Biochemistry and Molecular Biology from Georgetown University Medical Center. In addition to her commitment to research, Fleming has dedicated significant time ...
Better understanding cerebral palsy pain types could lead to better treatment
2024-08-07
Pain management is an important component of caring for adults with cerebral palsy.
However, it's the least understood comorbidity in the adult cerebral palsy population.
A study led by Mark Peterson, Ph.D., M.S., FACSM, a professor of physical medicine and rehabilitation at University of Michigan Health, found that adults living with cerebral palsy had a very high occurrence of pain, with 90% having a pain history and 74% having multiple diagnoses of pain coming from different origins such as the lower back, irritable bowels, joint arthritis and chronic ...
How ribosomes in our cells enable protein folding
2024-08-07
Scientists at UCL have discovered a novel role played by ribosomes during the folding of new proteins in cells, described in their paper in Nature.
Ribosomes, the cell’s dedicated molecular machines for protein synthesis, make all proteins in life and do so by piecing together one amino acid building block at a time. As they are being synthesised, these nascent proteins simultaneously attempt to fold while still associated to their parent ribosome, referred to as co-translational protein folding.
Understanding how exactly ...
Asthma emergencies spike when allergenic pollen blooms
2024-08-07
ITHACA, N.Y. – A new Cornell University study that tracks how many asthma-related emergency room visits result from pollen in metropolitan areas highlights the importance of knowing local plants and the need for developing science-based pollen forecasts.
Such forecasts could alert vulnerable individuals on days when they should consider staying indoors or taking allergy medications ahead of time.
“Even though the percent of asthma-related emergency department visits associated with pollen overall was only a few percent on an annual basis, ...
Disaster plant pathology: solutions to combat agricultural threats from disasters
2024-08-07
An often-overlooked component of natural and human-driven disasters is their potential to affect plant health and thus food security at domestic and international scales. Most disasters have indirect effects on plant health through factors such as disruptions to supply chains and damaged infrastructure, but there is also the potential for direct effects from disasters, such as pathogen or vector dispersal caused by floods, hurricanes, and human migration. These occurrences are rarely isolated and instead often occur simultaneously. We have seen examples of the concurrence of disasters in recent history through events such as market disruptions ...
Higher glucose levels worsen prognosis in ischemic stroke patients
2024-08-07
Having higher than usual blood sugar levels at the time of hospital admission for an ischemic stroke significantly increases the risk of a poor functional prognosis or death within three months of the stroke. This is the main conclusion of a study by the Endocrinology and Nutrition Services and the Neurology Department of Hospital del Mar, with researchers from the hospital's Research Institute, the RICORS-ICTUS network, and the CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM). The study ...
USC Norris Comprehensive Cancer Center to Open Radiation Oncology and Imaging Center in Newport Beach
2024-08-07
LOS ANGELES — USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, will open a Newport Beach location offering the latest advancements in radiation therapy and diagnostic imaging. The treatment center, which will open in early 2025, will feature cutting-edge cancer technologies that are yet to be available in Orange County, providing new therapeutic options and optimizing patient outcomes.
The new location address is 4590 MacArthur Blvd. in Newport Beach, less than 15 minutes away from USC Norris’ oncology centers in Newport Beach and Irvine. Those centers are staffed by respected oncologists who have served Orange County for decades, ...